Lahar Mehta
About Lahar Mehta
Lahar Mehta serves as the Vice President and Head of Global Clinical Development at Amylyx Pharmaceuticals. With extensive experience in clinical development across various organizations, he has held significant roles at Biogen, Amgen, and Genentech, among others.
Current Role at Amylyx Pharmaceuticals
Lahar Mehta serves as the Vice President and Head of Global Clinical Development at Amylyx Pharmaceuticals. He has held this position since 2021, contributing to the company's clinical strategies and development processes in Cambridge, Massachusetts. His role involves overseeing clinical trials and ensuring compliance with regulatory standards.
Previous Experience in Clinical Development
Before joining Amylyx Pharmaceuticals, Lahar Mehta held several significant positions in the field of clinical development. He worked at Annexon Biosciences as Vice President of Clinical Development from 2020 to 2021. Prior to that, he was a Medical Director at Amgen from 2016 to 2018 and served as a Senior Medical Director at Genentech from 2018 to 2019. His experience spans various therapeutic areas and includes leadership in clinical trial design and execution.
Educational Background
Lahar Mehta has a comprehensive educational background in medicine and business. He earned his Doctor of Medicine (M.D.) from Meharry Medical College from 1995 to 1999. He completed a Neurology Residency Program at the University of Utah School of Medicine from 2003 to 2006. Additionally, he studied Experimental Therapeutics and Neuroimmunology at the University of Rochester, achieving a Fellowship from 2007 to 2009. He also holds a Bachelor of Science in Business Administration from Washington University in St. Louis, obtained from 1990 to 1994.
Leadership Roles in Medical Institutions
Lahar Mehta has held leadership positions in various medical institutions. He served as Chief Resident at the University of Utah Hospitals and Clinics from 2005 to 2006. He was also an Instructor in Neurology at the University of Rochester Medical Center from 2007 to 2009. His experience in these roles contributed to his expertise in clinical education and patient care.
Research Contributions and Publications
Lahar Mehta is recognized for his contributions to research in neurology. He is the lead author of a publication on proteomic analyses in Alzheimer's Disease, which was presented at the Clinical Trials on Alzheimer’s Disease (CTAD) conference in October 2023. This work highlights his involvement in advancing understanding and treatment options for neurodegenerative diseases.